These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19995841)

  • 1. Assessing visual pathway function in multiple sclerosis patients with multifocal visual evoked potentials.
    Laron M; Cheng H; Zhang B; Schiffman JS; Tang RA; Frishman LJ
    Mult Scler; 2009 Dec; 15(12):1431-41. PubMed ID: 19995841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of multifocal visual evoked potential, standard automated perimetry and optical coherence tomography in assessing visual pathway in multiple sclerosis patients.
    Laron M; Cheng H; Zhang B; Schiffman JS; Tang RA; Frishman LJ
    Mult Scler; 2010 Apr; 16(4):412-26. PubMed ID: 20207786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifocal visual evoked potential analysis of inflammatory or demyelinating optic neuritis.
    Fraser CL; Klistorner A; Graham SL; Garrick R; Billson FA; Grigg JR
    Ophthalmology; 2006 Feb; 113(2):323.e1-323.e2. PubMed ID: 16406544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of multifocal and conventional visual evoked potential techniques in patients with optic neuritis/multiple sclerosis.
    Grover LK; Hood DC; Ghadiali Q; Grippo TM; Wenick AS; Greenstein VC; Behrens MM; Odel JG
    Doc Ophthalmol; 2008 Sep; 117(2):121-8. PubMed ID: 18204943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latency of Multifocal Visual Evoked Potential in Multiple Sclerosis: A Visual Pathway Biomarker for Clinical Trials of Remyelinating Therapies.
    Klistorner A; Triplett JD; Barnett MH; Yiannikas C; Barton J; Parratt J; You Y; Graham SL
    J Clin Neurophysiol; 2021 May; 38(3):186-191. PubMed ID: 33235179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifocal VEP assessment of optic neuritis evolution.
    Alshowaeir D; Yannikas C; Garrick R; Van Der Walt A; Graham SL; Fraser C; Klistorner A
    Clin Neurophysiol; 2015 Aug; 126(8):1617-23. PubMed ID: 25481337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of visual evoked potentials and spectral domain optical coherence tomography in early relapsing remitting multiple sclerosis.
    Behbehani R; Ahmed S; Al-Hashel J; Rousseff RT; Alroughani R
    Mult Scler Relat Disord; 2017 Feb; 12():15-19. PubMed ID: 28283099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereoacuity testing discloses abnormalities in multiple sclerosis without optic neuritis.
    Sobaci G; Demirkaya S; Gundogan FC; Mutlu FM
    J Neuroophthalmol; 2009 Sep; 29(3):197-202. PubMed ID: 19726941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empirical mode decomposition processing to improve multifocal-visual-evoked-potential signal analysis in multiple sclerosis.
    de Santiago L; Sánchez-Morla E; Blanco R; Miguel JM; Amo C; Ortiz Del Castillo M; López A; Boquete L
    PLoS One; 2018; 13(4):e0194964. PubMed ID: 29677200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial tuning function of pattern visual evoked potentials in multiple sclerosis patients without optic neuritis history.
    Taş A; Cakir Gundogan F; Akgun H; Erdem U; Sobaci G
    Med Glas (Zenica); 2013 Feb; 10(1):99-105. PubMed ID: 23348170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axonal loss in non-optic neuritis eyes of patients with multiple sclerosis linked to delayed visual evoked potential.
    Klistorner A; Garrick R; Barnett MH; Graham SL; Arvind H; Sriram P; Yiannikas C
    Neurology; 2013 Jan; 80(3):242-5. PubMed ID: 23269599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Color vision versus pattern visual evoked potentials in the assessment of subclinical optic pathway involvement in multiple sclerosis.
    Gundogan FC; Tas A; Altun S; Oz O; Erdem U; Sobaci G
    Indian J Ophthalmol; 2013 Mar; 61(3):100-3. PubMed ID: 23514643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of visual evoked potential abnormalities in multiple sclerosis and optic neuritis.
    Alshuaib WB
    Electromyogr Clin Neurophysiol; 2000 Jun; 40(4):243-52. PubMed ID: 10907603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed P100-Like Latencies in Multiple Sclerosis: A Preliminary Investigation Using Visual Evoked Spread Spectrum Analysis.
    Kiiski HS; Ní Riada S; Lalor EC; Gonçalves NR; Nolan H; Whelan R; Lonergan R; Kelly S; O'Brien MC; Kinsella K; Bramham J; Burke T; Ó Donnchadha S; Hutchinson M; Tubridy N; Reilly RB
    PLoS One; 2016; 11(1):e0146084. PubMed ID: 26726800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining abnormal interocular latencies of multifocal visual evoked potentials.
    Hood DC; Zhang X; Rodarte C; Yang EB; Ohri N; Fortune B; Johnson CA
    Doc Ophthalmol; 2004 Sep; 109(2):177-87. PubMed ID: 15881264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of multifocal visual evoked potential and traditional visual evoked potential in normal and multiple sclerosis eyes.
    Narayanan D; Cheng H; Tang RA; Frishman LJ
    Doc Ophthalmol; 2015 Feb; 130(1):31-41. PubMed ID: 25351235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sparse multifocal stimuli for the detection of multiple sclerosis.
    Ruseckaite R; Maddess T; Danta G; Lueck CJ; James AC
    Ann Neurol; 2005 Jun; 57(6):904-13. PubMed ID: 15929047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifocal visual evoked potential latency analysis: predicting progression to multiple sclerosis.
    Fraser C; Klistorner A; Graham S; Garrick R; Billson F; Grigg J
    Arch Neurol; 2006 Jun; 63(6):847-50. PubMed ID: 16769865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual evoked potentials in multiple sclerosis patients treated with interferon beta-1a.
    Liscić RM; Brecelj J
    Croat Med J; 2004 Jun; 45(3):323-7. PubMed ID: 15185427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional assessment of the visual pathway with multifocal visual evoked potentials, and their relationship with disability in patients with multiple sclerosis.
    Blanco R; Pérez-Rico C; Puertas-Muñoz I; Ayuso-Peralta L; Boquete L; Arévalo-Serrano J
    Mult Scler; 2014 Feb; 20(2):183-91. PubMed ID: 23828868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.